Literature DB >> 5284416

Clinical experiences in immunotherapy of cancer.

E T Krementz, M S Samuels, J H Wallace, E N Benes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5284416

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  8 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  The role of circulating antibody in the control of metastases.

Authors:  M G Lewis
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  Immune therapy of malignant melanoma.

Authors: 
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

5.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

6.  Virulence of six strains of Mycobacterium bovis (BCG) in mice.

Authors:  N A Sher; S D Chaparas; J Pearson; M Chirigos
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

7.  Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.

Authors:  A Bekierkunst; L Wang; R Toubiana; E Lederer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

Review 8.  Progress of immunotherapy in the treatment of malignant melanoma.

Authors:  S Ariyan
Journal:  Yale J Biol Med       Date:  1975-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.